Cellular Therapy Shows Promise in Advanced Heart Failure Patients
A novel approach using bone marrow-derived cells could offer new hope for those with few remaining treatment options
Topline
In patients with advanced heart failure, direct injection of autologous mononuclear cells into damaged heart tissue failed to meet the primary endpoint in a major trial, but still showed encouraging results across multiple hard endpoints, prompting the launch of a follow-up FDA-approved study.
Study Details
Presented at the 2025 American College of…
